Skip to main content
Top
Published in: Acta Neurochirurgica 9/2012

01-09-2012 | Clinical Article

The IMPACT prognosis calculator used in patients with severe traumatic brain injury treated with an ICP-targeted therapy

Authors: Magnus Olivecrona, Lars-Owe D. Koskinen

Published in: Acta Neurochirurgica | Issue 9/2012

Login to get access

Abstract

Background

The prognosis of severe traumatic brain injury (sTBI) is important. The International Mission on Prognosis in Traumatic Brain Injury (IMPACT) study group has developed a prediction calculator for the outcome of patients with sTBI, and this has been made available on the World Wide Web. We have studied the use of the IMPACT calculator on sTBI patients treated with an ICP-targeted therapy based on the Lund concept.

Method

The individual clinical data of patients in a prospective sTBI protocol-driven trial of the treatment of sTBI using the Lund concept were entered into the prognosis calculator, and the individual prognosis for each patient was calculated and compared with the actual outcome at 6 months.

Findings

The use of the IMPACT calculator led to an overestimation of mortality and of an unfavourable outcome. Compared with the IMPACT database, the absolute risk reduction (ARR) for mortality was 13.6 %. There is a statistically significant probability for the prediction of mortality and unfavourable outcome. A ROC curve analysis shows an area under the curve (AUC) in the Core model for mortality of 0.744 and of unfavourable outcome of 0.731, in the Extended model of 0.751 and 0.721 respectively, and in the Lab model of 0.779 and 0.810 respectively.

Conclusions

The IMPACT prognosis calculator should be used with caution for the prediction of outcome for an individual patient with sTBI treated with an ICP-targeted therapy based on the Lund concept. We conclude that we have to initiate treatment in all patients with blunt sTBI and an initial ICP > 10 mmHg. It seems that the outcome in sTBI patients treated in this fashion is better than would have been expected from the IMPACT prognosis.
Literature
1.
go back to reference (1994) A multicenter trial of the efficacy of nimodipine on outcome after severe head injury. The European Study Group on Nimodipine in Severe Head Injury. J Neurosurg 80:797–804 (1994) A multicenter trial of the efficacy of nimodipine on outcome after severe head injury. The European Study Group on Nimodipine in Severe Head Injury. J Neurosurg 80:797–804
2.
go back to reference Asgeirsson B, Grände PO, Nordström CH (1994) A new therapy of post-trauma brain oedema based on haemodynamic principles for brain volume regulation. Intensive Care Med 20:260–267PubMedCrossRef Asgeirsson B, Grände PO, Nordström CH (1994) A new therapy of post-trauma brain oedema based on haemodynamic principles for brain volume regulation. Intensive Care Med 20:260–267PubMedCrossRef
3.
go back to reference Chesnut RM, Marshall LF, Klauber MR, Blunt BA, Baldwin N, Eisenberg HM, Jane JA, Marmarou A, Foulkes MA (1993) The role of secondary brain injury in determining outcome from severe head injury. J Trauma 34:216–222PubMedCrossRef Chesnut RM, Marshall LF, Klauber MR, Blunt BA, Baldwin N, Eisenberg HM, Jane JA, Marmarou A, Foulkes MA (1993) The role of secondary brain injury in determining outcome from severe head injury. J Trauma 34:216–222PubMedCrossRef
4.
go back to reference Hippocrates (1928) Hippocrates Volume III: on wounds in the head, In the Surgery, Fractures, Joints, Moclion translated by E.T. Withington Harvard University Press, Cambridge, MA, London England, pp 7–51 Hippocrates (1928) Hippocrates Volume III: on wounds in the head, In the Surgery, Fractures, Joints, Moclion translated by E.T. Withington Harvard University Press, Cambridge, MA, London England, pp 7–51
5.
go back to reference Hukkelhoven CW, Steyerberg EW, Habbema JD, Farace E, Marmarou A, Murray GD, Marshall LF, Maas AI (2005) Predicting outcome after traumatic brain injury: development and validation of a prognostic score based on admission characteristics. J Neurotrauma 22:1025–1039PubMedCrossRef Hukkelhoven CW, Steyerberg EW, Habbema JD, Farace E, Marmarou A, Murray GD, Marshall LF, Maas AI (2005) Predicting outcome after traumatic brain injury: development and validation of a prognostic score based on admission characteristics. J Neurotrauma 22:1025–1039PubMedCrossRef
6.
7.
go back to reference Jennett B, Snoek J, Bond MR, Brooks N (1981) Disability after severe head injury: observations on the use of the Glasgow Outcome Scale. J Neurol Neurosurg Psychiatry 44:285–293PubMedCrossRef Jennett B, Snoek J, Bond MR, Brooks N (1981) Disability after severe head injury: observations on the use of the Glasgow Outcome Scale. J Neurol Neurosurg Psychiatry 44:285–293PubMedCrossRef
8.
go back to reference Maas AI, Steyerberg EW, Marmarou A, McHugh GS, Lingsma HF, Butcher I, Lu J, Weir J, Roozenbeek B, Murray GD (2010) IMPACT recommendations for improving the design and analysis of clinical trials in moderate to severe traumatic brain injury. Neurotherapeutics 7:127–134PubMedCrossRef Maas AI, Steyerberg EW, Marmarou A, McHugh GS, Lingsma HF, Butcher I, Lu J, Weir J, Roozenbeek B, Murray GD (2010) IMPACT recommendations for improving the design and analysis of clinical trials in moderate to severe traumatic brain injury. Neurotherapeutics 7:127–134PubMedCrossRef
9.
go back to reference Marmarou A, Lu J, Butcher I, McHugh GS, Mushkudiani NA, Murray GD, Steyerberg EW, Maas AI (2007) IMPACT database of traumatic brain injury: design and description. J Neurotrauma 24:239–250PubMedCrossRef Marmarou A, Lu J, Butcher I, McHugh GS, Mushkudiani NA, Murray GD, Steyerberg EW, Maas AI (2007) IMPACT database of traumatic brain injury: design and description. J Neurotrauma 24:239–250PubMedCrossRef
10.
go back to reference Marmarou A, Nichols J, Burgess J, Newell D, Troha J, Burnham D, Pitts L (1999) Effects of the bradykinin antagonist Bradycor (deltibant, CP-1027) in severe traumatic brain injury: results of a multi-center, randomized, placebo-controlled trial. American Brain Injury Consortium Study Group. J Neurotrauma 16:431–444PubMedCrossRef Marmarou A, Nichols J, Burgess J, Newell D, Troha J, Burnham D, Pitts L (1999) Effects of the bradykinin antagonist Bradycor (deltibant, CP-1027) in severe traumatic brain injury: results of a multi-center, randomized, placebo-controlled trial. American Brain Injury Consortium Study Group. J Neurotrauma 16:431–444PubMedCrossRef
11.
go back to reference Marshall LF, Maas AI, Marshall SB, Bricolo A, Fearnside M, Iannotti F, Klauber MR, Lagarrigue J, Lobato R, Persson L, Pickard JD, Piek J, Servadei F, Wellis GN, Morris GF, Means ED, Musch B (1998) A multicenter trial on the efficacy of using tirilazad mesylate in cases of head injury. J Neurosurg 89:519–525PubMedCrossRef Marshall LF, Maas AI, Marshall SB, Bricolo A, Fearnside M, Iannotti F, Klauber MR, Lagarrigue J, Lobato R, Persson L, Pickard JD, Piek J, Servadei F, Wellis GN, Morris GF, Means ED, Musch B (1998) A multicenter trial on the efficacy of using tirilazad mesylate in cases of head injury. J Neurosurg 89:519–525PubMedCrossRef
12.
go back to reference Marshall LF, Marshall SH, Klauber MR, van Berkum CM, Eisenberg HM, Jane JA, Lueressen TG, Marmarou A, Foulkes MA (1991) A new classification of head injury based on computerized tomography. J Neurosurg 75:s14–s20 Marshall LF, Marshall SH, Klauber MR, van Berkum CM, Eisenberg HM, Jane JA, Lueressen TG, Marmarou A, Foulkes MA (1991) A new classification of head injury based on computerized tomography. J Neurosurg 75:s14–s20
13.
go back to reference Murray GD, Butcher I, McHugh GS, Lu J, Mushkudiani NA, Maas AI, Marmarou A, Steyerberg EW (2007) Multivariable prognostic analysis in traumatic brain injury: results from the IMPACT study. J Neurotrauma 24:329–337PubMedCrossRef Murray GD, Butcher I, McHugh GS, Lu J, Mushkudiani NA, Maas AI, Marmarou A, Steyerberg EW (2007) Multivariable prognostic analysis in traumatic brain injury: results from the IMPACT study. J Neurotrauma 24:329–337PubMedCrossRef
14.
go back to reference Olivecrona M, Rodling-Wahlström M, Naredi S, Koskinen L-OD (2009) Prostacylin treatment in severe traumatic brain injury—a microdialysis and outcome study. J Neurotrauma 26:1251–1262PubMedCrossRef Olivecrona M, Rodling-Wahlström M, Naredi S, Koskinen L-OD (2009) Prostacylin treatment in severe traumatic brain injury—a microdialysis and outcome study. J Neurotrauma 26:1251–1262PubMedCrossRef
15.
go back to reference Olivecrona M, Rodling-Wahlström M, Naredi S, Koskinen LO (2007) Effective ICP reduction by decompressive craniectomy in patients with severe traumatic brain injury treated by an ICP-targeted therapy. J Neurotrauma 24:927–935PubMedCrossRef Olivecrona M, Rodling-Wahlström M, Naredi S, Koskinen LO (2007) Effective ICP reduction by decompressive craniectomy in patients with severe traumatic brain injury treated by an ICP-targeted therapy. J Neurotrauma 24:927–935PubMedCrossRef
16.
go back to reference Steyerberg EW, Mushkudiani N, Perel P, Butcher I, Lu J, McHugh GS, Murray GD, Marmarou A, Roberts I, Habbema JD, Maas AI (2008) Predicting outcome after traumatic brain injury: development and international validation of prognostic scores based on admission characteristics. PLoS Med 5:e165, discussion e165PubMedCrossRef Steyerberg EW, Mushkudiani N, Perel P, Butcher I, Lu J, McHugh GS, Murray GD, Marmarou A, Roberts I, Habbema JD, Maas AI (2008) Predicting outcome after traumatic brain injury: development and international validation of prognostic scores based on admission characteristics. PLoS Med 5:e165, discussion e165PubMedCrossRef
17.
go back to reference Wilson JT, Pettigrew LE, Teasdale GM (1998) Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: guidelines for their use. J Neurotrauma 15:573–585PubMedCrossRef Wilson JT, Pettigrew LE, Teasdale GM (1998) Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: guidelines for their use. J Neurotrauma 15:573–585PubMedCrossRef
18.
go back to reference Young B, Runge JW, Waxman KS, Harrington T, Wilberger J, Muizelaar JP, Boddy A, Kupiec JW (1996) Effects of pegorgotein on neurologic outcome of patients with severe head injury. A multicenter, randomized controlled trial. JAMA 276:538–543PubMedCrossRef Young B, Runge JW, Waxman KS, Harrington T, Wilberger J, Muizelaar JP, Boddy A, Kupiec JW (1996) Effects of pegorgotein on neurologic outcome of patients with severe head injury. A multicenter, randomized controlled trial. JAMA 276:538–543PubMedCrossRef
Metadata
Title
The IMPACT prognosis calculator used in patients with severe traumatic brain injury treated with an ICP-targeted therapy
Authors
Magnus Olivecrona
Lars-Owe D. Koskinen
Publication date
01-09-2012
Publisher
Springer Vienna
Published in
Acta Neurochirurgica / Issue 9/2012
Print ISSN: 0001-6268
Electronic ISSN: 0942-0940
DOI
https://doi.org/10.1007/s00701-012-1351-z

Other articles of this Issue 9/2012

Acta Neurochirurgica 9/2012 Go to the issue